🇺🇸 Simvastatin plus clopidogrel in United States

Simvastatin plus clopidogrel (Simvastatin plus clopidogrel) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Simvastatin plus clopidogrel in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Simvastatin plus clopidogrel approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Simvastatin plus clopidogrel in United States?

Federal University of São Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.